“We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for Translational Medicine. “And TNF-α is still the most contested—and the most ...
Currently, treatment decisions for people with Crohn's disease are based on clinical judgement and 'trial and error', so adapting treatment to suit the person may be difficult. People whose disease ...
Anti-tumor necrosis factor alpha (TNF-alpha) inhibitors are associated with an increased risk for multiple sclerosis (MS), especially among patients with rheumatic disease (RD), new research shows.
The assessment compared 6 intervention tests (enzyme-linked immunosorbent assay [ELISA] tests: Promonitor, IDKmonitor, LISA‑TRACKER, RIDASCREEN, MabTrack, and in-house tests used by Sanquin Diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results